Interstate commerce continues to be at the forefront of the industry's collective mind as we look for solutions to incongruence of supply and demand, stalled equity programs, and fierce competition between and among both licensed participants and illicit businesses.
Focusing on the Cannabis Administration and Opportunity Act (CAOA), the Marijuana Opportunity Reinvestment and Expungement Act (MORE), and the States Reform Act (SRA), our panelists will discuss how these proposals would change how the the relevant agencies (such as USDA, FDA, TTB, and PTO) regulate the cannabis sector.
Since the 2018 Farm Bill legalized hemp, there are now two distinct commercial industries: pharmaceuticals / wellness and industrial. In the pharmaceutical and consumer wellness areas, there is an explosion of innovation and new products. In the industrial market, there is increasing interest in light of sustainability and carbon capture considerations.
This is the final installment of INCBA’s Business Law - Formation series. This panel will discuss the nuts and bolts of raising money including, securities laws, what is a security, registration requirements, exemptions to registration, types of investment vehicles, and investor disclosure documents.
In this CLE, you will learn about best practices and how to avoid common pitfalls in the rules of professional conduct. The panel will also provide an update on current proposals growing out of the attorney-as-gatekeeper discussion.
In any industry, M&A is challenging. In cannabis, the issues can be even more complex. This deeper dive panel will focus on five of the most difficult legal issues to manage in these transactions.
Given the rapid developments that have taken place in just a short year, clients looking to enter the New York cannabis market will likely have many questions. Prepare yourself for these inevitable conversations now by signing up for our webinar where our legal experts will: (i) offer a general overview of the MRTA and adult-use licensing; (ii) break down recently-created adult-use conditional license types, the applicable eligibility criteria, and the potential impact of these conditional licenses on the State’s broader social and economic equity program; and (iii) explain how the State’s medical regulations will change if the proposed changes are adopted and what that means for the existing medical market, the adult-use market, and beyond. If you’re looking for a lively and informative discussion about all things cannabis in the Empire State, look no further – we’ve got you covered!
Participants will learn about the basic limitations and barriers of the cannabis market in Poland from the perspective of cultivators, manufacturers, sellers and patients.
Attendees will gain an overview of the UK Cannabis markets, including an overview of the small but growing medical segment, as well as the booming CBD and wellness industries.
In this session, hear from attorneys who are actively working on applications in the Garden State and with clients who are investing in New Jersey or otherwise gearing up for future submissions. Learn about unique-to-New Jersey license types, such as the “Conditional License,” enabling prospective operators to apply for a license without site control (subject to income restrictions), the “Micro-license,” a 2500 square foot facility for which there are no caps (subject to residency requirements), priorities in licensing, and creative opportunities to participate in the market distinct from ownership (via “Financial Source Agreement” or “Management Services Agreement”). Also learn about how the regulatory process is unfolding and how administrative delays are impacting the licensing process and accompanying operational timelines and legal transactions.